BACKGROUND: Silent infarction is common in poor-grade subarachnoid hemorrhage (SAH) patients and associated with poor outcome. Invasive neuromonitoring devices may detect changes in cerebral metabolism and oxygenation. METHODS: From a consecutive series of 32 poor-grade SAH patients we identified all CT-scans obtained during multimodal neuromonitoring and analyzed microdialysis parameters and brain tissue oxygen tension (PbtO2) preceding CT-scanning. RESULTS: Eighteen percent of the reviewed head-CTs (12/67) revealed new infarcts. Of the eight infarcts in the vascular territory of the neuromonitoring, seven were clinically silent. Neuromonitoring changes preceding radiological evidence of infarction included lactate-pyruvate-ratio elevation and brain glucose decreases when compared to those with distant or no ischemia (P ≤ 0.03, respectively). PbtO2 was lower, but this did not reach statistical significance. CONCLUSIONS: These data suggest that there may be distinct changes in brain metabolism and oxygenation associated with the development of silent infarction within the monitored vascular territory in poor-grade SAH patients. Larger prospective studies are needed to determine whether treatment triggered by neuromonitoring data has an impact on outcome.
BACKGROUND:Silent infarction is common in poor-grade subarachnoid hemorrhage (SAH) patients and associated with poor outcome. Invasive neuromonitoring devices may detect changes in cerebral metabolism and oxygenation. METHODS: From a consecutive series of 32 poor-grade SAHpatients we identified all CT-scans obtained during multimodal neuromonitoring and analyzed microdialysis parameters and brain tissue oxygen tension (PbtO2) preceding CT-scanning. RESULTS: Eighteen percent of the reviewed head-CTs (12/67) revealed new infarcts. Of the eight infarcts in the vascular territory of the neuromonitoring, seven were clinically silent. Neuromonitoring changes preceding radiological evidence of infarction included lactate-pyruvate-ratio elevation and brain glucose decreases when compared to those with distant or no ischemia (P ≤ 0.03, respectively). PbtO2 was lower, but this did not reach statistical significance. CONCLUSIONS: These data suggest that there may be distinct changes in brain metabolism and oxygenation associated with the development of silent infarction within the monitored vascular territory in poor-grade SAHpatients. Larger prospective studies are needed to determine whether treatment triggered by neuromonitoring data has an impact on outcome.
Authors: Joshua B Bederson; E Sander Connolly; H Hunt Batjer; Ralph G Dacey; Jacques E Dion; Michael N Diringer; John E Duldner; Robert E Harbaugh; Aman B Patel; Robert H Rosenwasser Journal: Stroke Date: 2009-01-22 Impact factor: 7.914
Authors: Emmanuel Carrera; J Michael Schmidt; Mauro Oddo; Luis Fernandez; Jan Claassen; David Seder; Kiwon Lee; Neeraj Badjatia; E Sander Connolly; Stephan A Mayer Journal: Neurosurgery Date: 2009-08 Impact factor: 4.654
Authors: Ursula Beckmann; Donna M Gillies; Sean M Berenholtz; Albert W Wu; Peter Pronovost Journal: Intensive Care Med Date: 2004-02-26 Impact factor: 17.440
Authors: J Michael Schmidt; Katja E Wartenberg; Andres Fernandez; Jan Claassen; Fred Rincon; Noeleen D Ostapkovich; Neeraj Badjatia; Augusto Parra; E Sander Connolly; Stephan A Mayer Journal: J Neurosurg Date: 2008-12 Impact factor: 5.115
Authors: Ricardo J Komotar; J Michael Schmidt; Robert M Starke; Jan Claassen; Katja E Wartenberg; Kiwon Lee; Neeraj Badjatia; E Sander Connolly; Stephan A Mayer Journal: Neurosurgery Date: 2009-03 Impact factor: 4.654
Authors: R Morgan Stuart; Michael Schmidt; Pedro Kurtz; Allen Waziri; Raimund Helbok; Stephan A Mayer; Kiwon Lee; Neeraj Badjatia; Lawrence J Hirsch; E Sander Connolly; Jan Claassen Journal: Neurocrit Care Date: 2010-04 Impact factor: 3.210
Authors: H Alex Choi; Sang-Bae Ko; Huahiou Chen; Emily Gilmore; Amanda M Carpenter; Danielle Lee; Jan Claassen; Stephan A Mayer; J Michael Schmidt; Kiwon Lee; E Sander Connelly; Myunghee Paik; Neeraj Badjatia Journal: Neurocrit Care Date: 2012-06 Impact factor: 3.210
Authors: Sang-Bae Ko; H Alex Choi; Gunjan Parikh; Raimund Helbok; J Michael Schmidt; Kiwon Lee; Neeraj Badjatia; Jan Claassen; E Sander Connolly; Stephan A Mayer Journal: Stroke Date: 2011-08-18 Impact factor: 7.914
Authors: Raimund Helbok; Ronny Beer; Andreas Chemelli; Florian Sohm; Gregor Broessner; Peter Lackner; Martin Sojer; Bettina Pfausler; Claudius Thomé; Erich Schmutzhard Journal: Neurocrit Care Date: 2011-06 Impact factor: 3.210
Authors: Evan D McConnell; Helen S Wei; Katherine M Reitz; Hongyi Kang; Takahiro Takano; G Edward Vates; Maiken Nedergaard Journal: J Cereb Blood Flow Metab Date: 2015-10-14 Impact factor: 6.200